IPO registrations (S-1, F-1) · Registrants
Morphic Holding, Inc.
- SEC CIK
- 1679363 · filings on EDGAR ↗
- Former names
- Morphic Holding, LLC (2016–2018)
- Registration
- Form S-1, first filed 2019-05-30, last 2019-06-24; 1 initial registration, 2 amendments
- Outcome
- Final prospectus filed 2019-06-27; declared effective 2019-06-26
- Industry (SIC)
- Pharmaceutical Preparations 2834
- Incorporated in
- DE
- Business address
- 35 GATEHOUSE DRIVE A2, Waltham, MA 02451
- EIN
- 47-3878772
- EDGAR entity type
- operating
- Insiders and CEO pay
- Morphic Holding, Inc. on the corporate pages
Offering terms
- Final price
- $15.00 per share (424B4 filed 2019-06-27, an initial public offering)
- Shares sold
- 6,000,000
- Gross proceeds
- $90,000,000 before underwriting discounts and any over-allotment option
- Listing
- Nasdaq under the symbol MORF
- Lead underwriters
- Wells Fargo; BMO Capital Markets; Cowen; Jefferies
Read from the cover pages of the filings listed under “Prospectus pages read” below; check the document for anything that matters.
On this site
- Form D issuer: Morphic Holding, Inc. EXACT (CIK (EXACT))
- SEC filer: Morphic Holding, Inc. EXACT (CIK (EXACT))
Filings 7
| Filed | Form | What it is | Name as filed | EDGAR |
|---|---|---|---|---|
| 2019-05-30 | S-1 | S-1 (registration) | Morphic Holding, Inc. | 0001047469-19-003383 ↗ |
| 2019-06-14 | S-1/A | S-1/A (amendment) | Morphic Holding, Inc. | 0001047469-19-003634 ↗ |
| 2019-06-24 | S-1/A | S-1/A (amendment) | Morphic Holding, Inc. | 0001047469-19-003803 ↗ |
| 2019-06-26 | S-1MEF | S-1MEF (added securities) | Morphic Holding, Inc. | 0001104659-19-037710 ↗ |
| 2019-06-26 | EFFECT | EFFECT (declared effective) | Morphic Holding, Inc. | 9999999995-19-001449 ↗ |
| 2019-06-27 | 424B4 | 424B4 (final prospectus) | Morphic Holding, Inc. | 0001047469-19-003926 ↗ |
| 2020-07-08 | EFFECT | EFFECT (declared effective) | Morphic Holding, Inc. | 9999999995-20-001718 ↗ |
Prospectus pages read 2
| Filed | Form | Read as | Range | Price | Shares | Proceeds | Listing | Underwriters | What was found | Document |
|---|---|---|---|---|---|---|---|---|---|---|
| 2019-06-24 | S-1/A | registration statement | $7.58 | 1,011,227 | $7,665,100 | 0 | primary document; price line, shares headline, proceeds computed | document ↗ | ||
| 2019-06-27 | 424B4 | final prospectus | $15.00 | 6,000,000 | $90,000,000 | Nasdaq MORF | 4 | primary document; price sentence, shares headline, proceeds table | document ↗ |
Officers, directors and large holders Forms 3, 4 and 5
| Insider | Role | Title | Filings | Years | On this site |
|---|---|---|---|---|---|
| BISCHOFBERGER NORBERT W | Director | 8 | 2019–2024 | ||
| Christensen Gustav | Director | 9 | 2019–2024 | ||
| Dalton Barbara | Director | 1 | 2019 | ||
| DeVaul William | Officer | General Counsel and Secretary | 18 | 2019–2024 | |
| Farrell Robert E Jr | Officer | EXECUTIVE VICE PRESIDENT; SVP Finance and CAO; VP Finance and Ops, Secretary | 27 | 2019–2024 | |
| GLAXOSMITHKLINE PLC | Director; Director,TenPercentOwner | 2 | 2019 | ||
| Goyal Vikas | Director | 5 | 2019–2021 | ||
| Kumar Nilesh | Director | 1 | 2019 | ||
| Lim Richard J. | TenPercentOwner | 2 | 2019 | ||
| Lugovskoy Alexey | Officer | Chief Development Officer | 10 | 2019–2020 | |
| Nashat Amir | Director | 11 | 2019–2024 | ||
| Nessi Claudio | TenPercentOwner | 2 | 2019 | ||
| Novo Holdings A/S | TenPercentOwner | 2 | 2019 | ||
| Omega Fund V GP, L.P. | Director; TenPercentOwner | 41 | 2019–2021 | ||
| Omega Fund V GP Manager, Ltd. | Director; TenPercentOwner | 41 | 2019–2021 | ||
| Omega Fund V, L.P. | Director; TenPercentOwner | 41 | 2019–2021 | ||
| Paster Anne-Mari | TenPercentOwner | 2 | 2019 | ||
| Rogers Bruce | Officer | Chief Scientific Officer; President; PRESIDENT | 25 | 2019–2024 | |
| SLATTERY JOSEPH P | Director | 10 | 2019–2024 | ||
| SPRINGER TIMOTHY A | Director,TenPercentOwner | 17 | 2019–2024 | ||
| Stampacchia Otello | Director; Director,TenPercentOwner | 44 | 2019–2021 | ||
| Tipirneni Praveen P. | Director,Officer | CEO; President and CEO | 26 | 2019–2024 | |
| Linde Peter | Officer | Chief Medical Officer | 6 | 2020–2021 | |
| SCHEGERIN MARC | Officer | CFO and COO | 16 | 2020–2024 | |
| Edwards Martin | Director | 9 | 2020–2024 | ||
| GRAY SUSANNAH | Director | 9 | 2021–2024 | ||
| Nanda Nisha | Director | 6 | 2021–2024 | ||
| Cooper Simon Peter | Officer | CMO | 3 | 2024 |
Everyone who filed an insider report for this company, from the SEC’s Insider Transactions Data Sets (2006 on). Person pages are matched by name and state only.
Private offerings before or after (Form D)
| First filed | Issuer | Industry | Offering | Sold | Investors | Filings |
|---|---|---|---|---|---|---|
| 2023-03-01 | Morphic Holding, Inc. | Biotechnology | $100,000,000 | $99,999,755 | 4 | 1 |
| 2018-10-01 | Morphic Holding, LLC | Biotechnology | $79,999,990 | $79,999,990 | 13 | 1 |
| 2016-07-13 | Morphic Holding, LLC | Biotechnology | $51,500,000 | $20,599,999 | 12 | 1 |
Data: SEC EDGAR. The quarterly full index (every S-1, S-1/A, F-1 and F-1/A since 1993, with the pricing prospectus, notice of effectiveness and withdrawal request of each registrant) and the company submissions data (SIC, state of incorporation, address, EIN, tickers, former names). Company details are what EDGAR holds today, not at the time of the filing.
Also on this site Fuzzy
| Record | Name as filed | Where | Dataset | Matched by |
|---|---|---|---|---|
| Form D issuer | Morphic Holding, Inc. | MA | Form D private offerings | CIK (EXACT) |
| SEC filer | Morphic Holding, Inc. | SEC filers (EDGAR) | CIK (EXACT) |
Matched by an identifier (EIN, CIK, CRD), by name and state or city, or by street address; a shared name or address is not proof of the same person or organization. Every link says how it was made; how the cross-referencing works.